CD95 ligand is expressed in Reed-Sternberg cells of Hodgkin's disease

Isao Sakuma, Tadashi Yoshino, Kunihiro Omonishi, Ritsuo Nishiuchi, Norihiro Teramoto, Hiroyuki Yanai, Kunimitsu Kawahara, Ichiro Kubonishi, Yoshinobu Matsuo, Tadaatsu Akagi

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Reed-Sternberg (RS) cells and their mononuclear variants, Hodgkin's (H) cells, are considered to be the neoplastic cells of Hodgkin's disease (HD). The cellular origin of H-RS cells remains the subject of considerable controversy, although most recent papers have claimed that H-RS cells are of B cell origin. Recently, however, it has been reported that some H-RS cells express granzyme B, as observed in cytotoxic T cells and/or natural killer cells, which also express CD95 ligand (FasL/APO-1L). In the present study, the expression of CD95L and granzyme B in H-RS cells of HD was investigated. CD95L was detected in H-RS cells in five of nine HD cases (one case of lymphocyte-rich classical HD, two of these cases of nodular sclerosis type, and two of four cases of mixed cellularity type). All three examined HD cell lines expressed CD95L in the cytoplasm, although cell surface expression was seen only in L428 cells. Three HD cases expressed both CD95L and granzyme B. It was concluded that CD95L is frequently expressed in H-RS cells, which is one of their notable characteristics; albeit it seems to be irrespective of cell lineage.

Original languageEnglish
Pages (from-to)103-109
Number of pages7
JournalPathology International
Volume49
Issue number2
DOIs
Publication statusPublished - 1999

Fingerprint

Reed-Sternberg Cells
Fas Ligand Protein
Hodgkin Disease
Granzymes
Sclerosis
Cell Lineage
Natural Killer Cells
Cytoplasm
B-Lymphocytes
Lymphocytes
T-Lymphocytes
Cell Line

Keywords

  • CD95 ligand
  • Granzyme B
  • Hodgkin's disease
  • Reed-Sternberg cell
  • T cell intracellular antigen 1

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

CD95 ligand is expressed in Reed-Sternberg cells of Hodgkin's disease. / Sakuma, Isao; Yoshino, Tadashi; Omonishi, Kunihiro; Nishiuchi, Ritsuo; Teramoto, Norihiro; Yanai, Hiroyuki; Kawahara, Kunimitsu; Kubonishi, Ichiro; Matsuo, Yoshinobu; Akagi, Tadaatsu.

In: Pathology International, Vol. 49, No. 2, 1999, p. 103-109.

Research output: Contribution to journalArticle

Sakuma, I, Yoshino, T, Omonishi, K, Nishiuchi, R, Teramoto, N, Yanai, H, Kawahara, K, Kubonishi, I, Matsuo, Y & Akagi, T 1999, 'CD95 ligand is expressed in Reed-Sternberg cells of Hodgkin's disease', Pathology International, vol. 49, no. 2, pp. 103-109. https://doi.org/10.1046/j.1440-1827.1999.00830.x
Sakuma, Isao ; Yoshino, Tadashi ; Omonishi, Kunihiro ; Nishiuchi, Ritsuo ; Teramoto, Norihiro ; Yanai, Hiroyuki ; Kawahara, Kunimitsu ; Kubonishi, Ichiro ; Matsuo, Yoshinobu ; Akagi, Tadaatsu. / CD95 ligand is expressed in Reed-Sternberg cells of Hodgkin's disease. In: Pathology International. 1999 ; Vol. 49, No. 2. pp. 103-109.
@article{897511bdd3a949a0985ee87ac9b833f6,
title = "CD95 ligand is expressed in Reed-Sternberg cells of Hodgkin's disease",
abstract = "Reed-Sternberg (RS) cells and their mononuclear variants, Hodgkin's (H) cells, are considered to be the neoplastic cells of Hodgkin's disease (HD). The cellular origin of H-RS cells remains the subject of considerable controversy, although most recent papers have claimed that H-RS cells are of B cell origin. Recently, however, it has been reported that some H-RS cells express granzyme B, as observed in cytotoxic T cells and/or natural killer cells, which also express CD95 ligand (FasL/APO-1L). In the present study, the expression of CD95L and granzyme B in H-RS cells of HD was investigated. CD95L was detected in H-RS cells in five of nine HD cases (one case of lymphocyte-rich classical HD, two of these cases of nodular sclerosis type, and two of four cases of mixed cellularity type). All three examined HD cell lines expressed CD95L in the cytoplasm, although cell surface expression was seen only in L428 cells. Three HD cases expressed both CD95L and granzyme B. It was concluded that CD95L is frequently expressed in H-RS cells, which is one of their notable characteristics; albeit it seems to be irrespective of cell lineage.",
keywords = "CD95 ligand, Granzyme B, Hodgkin's disease, Reed-Sternberg cell, T cell intracellular antigen 1",
author = "Isao Sakuma and Tadashi Yoshino and Kunihiro Omonishi and Ritsuo Nishiuchi and Norihiro Teramoto and Hiroyuki Yanai and Kunimitsu Kawahara and Ichiro Kubonishi and Yoshinobu Matsuo and Tadaatsu Akagi",
year = "1999",
doi = "10.1046/j.1440-1827.1999.00830.x",
language = "English",
volume = "49",
pages = "103--109",
journal = "Pathology International",
issn = "1320-5463",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - CD95 ligand is expressed in Reed-Sternberg cells of Hodgkin's disease

AU - Sakuma, Isao

AU - Yoshino, Tadashi

AU - Omonishi, Kunihiro

AU - Nishiuchi, Ritsuo

AU - Teramoto, Norihiro

AU - Yanai, Hiroyuki

AU - Kawahara, Kunimitsu

AU - Kubonishi, Ichiro

AU - Matsuo, Yoshinobu

AU - Akagi, Tadaatsu

PY - 1999

Y1 - 1999

N2 - Reed-Sternberg (RS) cells and their mononuclear variants, Hodgkin's (H) cells, are considered to be the neoplastic cells of Hodgkin's disease (HD). The cellular origin of H-RS cells remains the subject of considerable controversy, although most recent papers have claimed that H-RS cells are of B cell origin. Recently, however, it has been reported that some H-RS cells express granzyme B, as observed in cytotoxic T cells and/or natural killer cells, which also express CD95 ligand (FasL/APO-1L). In the present study, the expression of CD95L and granzyme B in H-RS cells of HD was investigated. CD95L was detected in H-RS cells in five of nine HD cases (one case of lymphocyte-rich classical HD, two of these cases of nodular sclerosis type, and two of four cases of mixed cellularity type). All three examined HD cell lines expressed CD95L in the cytoplasm, although cell surface expression was seen only in L428 cells. Three HD cases expressed both CD95L and granzyme B. It was concluded that CD95L is frequently expressed in H-RS cells, which is one of their notable characteristics; albeit it seems to be irrespective of cell lineage.

AB - Reed-Sternberg (RS) cells and their mononuclear variants, Hodgkin's (H) cells, are considered to be the neoplastic cells of Hodgkin's disease (HD). The cellular origin of H-RS cells remains the subject of considerable controversy, although most recent papers have claimed that H-RS cells are of B cell origin. Recently, however, it has been reported that some H-RS cells express granzyme B, as observed in cytotoxic T cells and/or natural killer cells, which also express CD95 ligand (FasL/APO-1L). In the present study, the expression of CD95L and granzyme B in H-RS cells of HD was investigated. CD95L was detected in H-RS cells in five of nine HD cases (one case of lymphocyte-rich classical HD, two of these cases of nodular sclerosis type, and two of four cases of mixed cellularity type). All three examined HD cell lines expressed CD95L in the cytoplasm, although cell surface expression was seen only in L428 cells. Three HD cases expressed both CD95L and granzyme B. It was concluded that CD95L is frequently expressed in H-RS cells, which is one of their notable characteristics; albeit it seems to be irrespective of cell lineage.

KW - CD95 ligand

KW - Granzyme B

KW - Hodgkin's disease

KW - Reed-Sternberg cell

KW - T cell intracellular antigen 1

UR - http://www.scopus.com/inward/record.url?scp=0033003298&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033003298&partnerID=8YFLogxK

U2 - 10.1046/j.1440-1827.1999.00830.x

DO - 10.1046/j.1440-1827.1999.00830.x

M3 - Article

VL - 49

SP - 103

EP - 109

JO - Pathology International

JF - Pathology International

SN - 1320-5463

IS - 2

ER -